ASCO GI 2023 Conference Coverage
M

ASCO GI 2023 Characterization of Long-Term Survivors in the TOPAZ-1 Study: Durvalumab or Placebo + Gemcitabine & Cisplatin in Advanced Biliary Tract Cancer

By ASCO GI 2023 Conference Coverage FEATURING Mohamed Bouattour
By ASCO GI 2023 Conference Coverage FEATURING Mohamed Bouattour
292 views
January 28, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
22:33
Integrity CE

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Feat. V. Lee, R. Kumar, N. Bhagat, E. Winslow
28:25
Integrity CE

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Feat. V. Lee, E. Christenson, N. Bhagat, E. Winslow
25:09
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC…

Feat. R. Kim, T. Biachi
16:40
Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

Feat. R. Kim, T. Biachi
09:13
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary C…

Feat. N. Uboha, K. Spencer, M. Cecchini
14:54
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…

Feat. L. Rimassa
11:27
Integrity CE

Hepatic Arterial Infusion for Primary Liver Cancer

Feat. K. Lafaro
15:49
Integrity CE

Updates in Targeted Therapies for Metastatic Biliary Tract Cancers

Feat. J. Harding
21:46
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Past, Present & Future Clinical M…

Feat. M. Ikeda
04:39
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor …

Feat. G. Abou-Alfa
06:51
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Biliary Tract Cancer"

Feat. A. Vogel
05:46
Penn Medicine Abramson Cancer Center

Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Ov…

Feat. T. Karasic
18:35
Total Health

Biliary Cancer Updates - 2023 ASCO® Direct Philadelphia

Feat. D. Lin
09:05
AACR 2023 Conference Coverage

AACR 2023 on KEYNOTE-966 Phase 3 Study: Pembro in Combination With G…

Feat. K. Kelley
10:28
Insights from 2024 ESMO GI Annual Meeting

ESMO GI 2024 Insights: Durvalumab + Chemo in Biliary Tract Cancer - …

Feat. D. Oh
03:50
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Post Hoc Analysis of the ABC-01, -02 and -…

Feat. A. Lamarca
06:42
ASCO 2022 Conference Coverage

ASCO 2022 on PROOF 301 Trial: Updates on Infigratinib vs. Gemcitabin…

Feat. G. Abou-Alfa
14:37
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Randomized, Double-Blind, Placebo-Control…

Feat. A. Batra
12:20
Integrity CE

Molecular Tumor Determinants of the Immune Microenvironment in Bilia…

Feat. D. Zabransky